ExploreWatchlistsPricing
  1. JP-listed companies
  2. ZERIA PHARMCEUTICAL CO., LTD.
  3. Financials
  4. Revenue growth (%)

ZERIA PHARMCEUTICAL CO., LTD. (4559)

Market cap
¥124.2B
P/E ratio
10.3x
Japanese pharmaceutical company that develops and sells prescription drugs, over-the-counter medications, and health products through multiple subsidiaries worldwide.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRevenue growth (%) YoY (%)
Mar 31, 20262.1-86.14%
Mar 31, 202515.3+42.46%
Mar 31, 202410.7-27.77%
Mar 31, 202314.9+101.49%
Mar 31, 20227.4-189.45%
Mar 31, 2021-8.2+263.44%
Mar 31, 2020-2.3-46.46%
Mar 31, 2019-4.2+886.05%
Mar 31, 2018-0.4-111.32%
Mar 31, 20173.8+58.33%
Mar 31, 20162.4-250.94%
Mar 31, 2015-1.6-109.77%
Mar 31, 201416.3+5714.29%
Mar 31, 20130.3

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat